Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,867,637 in approved orders during the month of August 2014, marking its fifth consecutive month of sales growth.
Main Avenue Pharmacy's revenue of $4.9 million during August represents a 19% increase over July.
In response to a PM I received, no, I do not believe that there are any convert noteholders who are actively working to manipulate the sp downward in order to get more shares.
This is because of several reasons:
(1)
SCRC has not entered into any additional convert notes that have variable conversion features since last OCT-2013.
(2)
Virtually all remaining convert notes that contained variable conversion features have already been extinguished, albeit primarily via conversion into dilutive shares. The past two 10Q's provide details on the lengthy list of these dilutive conversions.
(3)
As such, these convert noteholders have already gotten their shares long ago. There is nothing they can do currently that can impact any shares they get since they already received them.
(4)
In general, the only time that these convert noteholders would have any incentive to try to drive the sp down is within a small window of time PRIOR to submitting their notice of intent to convert to SCRC, as the terms of the convert notes typically provide that the conversion price will be a specified discount off the lowest prints (or lowest EOD closing price or lowest VWAP, whatever) over the xx days prior to providing their notice of intent to convert (with "xx" typically being anywhere from 10-20).
Hope this helps...
1000 share paint 42 seconds before the close. $96.50 + commission = money well spent for someone.
Well thought out post as usual. Makes sense and is the best explanation of this process taking place . common shareholders will have to wait their turn while pipes are digested thoroughly. Even if it takes another 9 months roughly. Hope things turn out this way. Gltu
I would say the main reason is no one knows this company exists. Bob only uses Joey Z and his crew to market it to the retail buyers on boards like this. If, and I mean IF Bob were to hire an actual IR firm (not the one man show he uses now) to start marketing this to the street we would see the movement that is needed. Until then, it will be whipped around this price point.
@FUDUDE,
So as to have a better context by which to evaluate both SCRC's PR's as well as SCRC's SEC filings, I was wondering if you may be able to shed some light on a company which you know well that is a remarkably close comp to SCRC: PAWS.
As we know, both companies re-invented themselves and entered the compounding pharmacy biz during Q1'14. Both companies base their compounding operations out of a single solitary brick-and-mortar location. Key differences are that PAWS is already running in excess of $100M in topline REVENUES (not simply "approved orders") per annum. But we also know that PAWS is licensed in 20-something states (correct me if I'm wrong on this one, FUDUDE) whereas SCRC is licensed currently in only 7 states. So the disparity in revenues may be a direct corrolation with the number of states each company is licensed to conduct business in.
As you have followed PAWS a lot longer than I have, my questions to you are as follows:
(1)
Would you know, or be able to find out, how many licensed pharmacists PAWS employes at its pharmacy?
(2)
Would you know, or be able to find out, whether it actually takes a licensed pharmacist to do the actual physical compounding? Or is it the case where so long as the "formula" is approved by a licensed pharmacist, then any pharmacy employee can create the mixture?
(3)
Would you know, or be able to find out, what the current backlog is from the time PAWS' pharmacy receives approval for an order and when it is actually able to get it compounded and shipped?
Ultimately, I believe that any info we can glean from PAWS can be a good comp for us to evaluate the PR's and SEC filings we are seeing from SCRC. The PAWS metrics can either affirm and re-inforce what we are seeing here w/SCRC, or it can raise potential red flags for us. Knowledge is power, so the more of it we can get, the better-informed our investing decisions will be on how to proceed.
TIA...
So in your expert opinion , what is holding this down and what will have to happen and when for this to run up ? If it runs ? It's the only reason everyone on this board is here for . Thanks
Could you do an analysis on the 500 share sell for .0915 @3:47?
At this point, all I can do is just try to average down till the street gets a hold of it. The last couple of PR didn't do very much. If, and I mean "if" they can get to CFP in Q3 and that is in the Q in November, we may finally get the market's attention. Here's hoping.
All those with .05 shares are aggressively, relentlessly selling their shares to make a .035- .04 astronomical profit per share of 70%+.
To think all they had to do was risk all their cash
in exchange for helping finance the company to succeed
and allowing others to realize their investment
I cannot believe in America, capitalism is even allowed.
Taking circumstantial events and immediately drawing guilty or negative conclusions is your methodology.
That is why I can not agree with most of your concluding statements.
Also I would think twice about your accusation of insider trading by B.S., J.Z. and the so-called 'core'. It could be trouble if you can not prove it.
Accusing another of crimes and violations is inappropriate on a message board.
No reason to urinate on the parade here.
However, his conclusions are usually so negatively biased
The recent accusation of J.Z. and the 'core' receiving inside information are typical.
He better have inside information
that can prove this or he will become liable to considerable legal and SEC penalties for his accusations !!
Core investors will do what they want to do.
No one will change their minds.
A fellow poster told me about your post where you made a statement that the CEO Bob S passed along inside information to Joe Z as well as the core to let them sell their .05 shares on July 21st?
Is that what we are led to believe?
Do you have proof of such a charge and how do you know?
I don't have anything to say about your posts.
The reason being I don't read them.
Way to long.
Is anyone else simply absolutely in shock that "BS" did not issue another mid-month revenue PR like he did last month??? LOL...
In the absence of REAL news, I would suggest that retail investors exercise patience and watch these CORE PIPE holding con artists cannibalize each other by continually undercutting each other's asks. We can't stop them from realizing gains on their .05 shares, but we can make sure that we don't overpay for their shares (the flipside of which is that by buying higher than necessary, we are also enabling them to realize more profit than they deserve). Let them keep liquidating until the sp gets as low as it can. Force them to have to settle for 70%, then 60%, then 50%, then 40%, etc, etc, etc. Their "loss" (if you can still call a 40-70% gain a "loss", LOL) will be YOUR gain.
As I've been saying for almost a year now, watch your entry/exit points. Wait for a confirmed bottom to show itself before buying in. If it ends up being .0821, then so be it and feel free adding to or starting a position around .09-ish. But with almost 15M shares of this .05 poison still lurking out there over the next several months, there would be at least a 50/50 probability that they will continue to undercut each other and drive the sp down further. Not saying it will, but there is no indicator out there yet that would warrant any reasonably knowledgeable investor buying in right now.
GLTA...
Edlongstock, thank you for your concern but whether I own .05 shares or not, or how many shares I own or do not own, is not anyone's business
another day, yet again, we are seeing those .05 shares being dumped. As of 11am, already zero volume today. As others predicted, those .05 owners are, continue to be and will be MASSIVE sellers.
What will the Main Ave figures be for August.
Can they hit the 4 million mark again.
Not only that but the massive selling confirms it has to be all .05 shares being sold. Like I said, it's just disgusting.
I have friends who invested cash to help finance FB, GOOG, MSFT and PLUG in exchange for "special" shares. Disgusting. I cannot believe private financing, risking all your cash, waiting a certain length of time, in exchange for lower priced shares, in order to help a company succeed, and thereby help other shareholders realize their investment, is even legal. Like I said, this is America. Go figure.
Paint right on time 14 seconds before market close. Down 6.7% instead of 11%. Was it really worth the $44 + commission?
November to Remember!
you're assuming that the announcement of ( all clear and ready to go) was accurate.. at this point I'm thinking it wasn't....
My original point has been made - awaiting regulatory approval. No spin, just the facts.
Why would they PR a PO for a product they can't even sell yet??
Quote:
There is NOTHING from a regulatory perspective that is preventing RapiMeds from being sold in Hong Kong for 6 months now.
End Quote
This is the flaw in your reasoning. Per the report, the regulatory red tape is exactly what is causing the delay.
Wait a minute, What are we doing at .096?
I thought we were going to .05? ;)
I think continued positive news from the company will send the stock higher than anyone on the wrong side of the trade will get hurt, going forward
The last time he checked, there was no short interest. But now, depending on whether you rely on NASDAQ, Interactive Brokers, shortsqueeze.com or some other service, the reported short interest is below 50,000 shares. Though this is a tiny fraction of the total OS, he said several traders can work in concert to borrow against the shares at the same time in an effort to "bid pin" the stock and move the sp down.
He said it is much easier for them to move the sp down than up, because it is very easy for them to spread fear and cause the typical retail long to sell out of fear.
Perhaps the folks over on the stock ethics board could take this on as a project and actually to the average retail investor some good for a change.
Your essay response shifting the issue does not change the underlying facts of my point. That is, there are facts expressed in the public domain to support that the delay for RapiMeds is being caused by red tape, not a lack of retail interest.
CHP, LOL I tried to explain that to the great one he seems to understand the math behind having 200k shares @ 20c and having 2 million shares at 5c he could have recouped all monies....
Strange way they work
Well, he just responded and stated the website Q&A would be updated in a few weeks.
I found what I believe to be a positive fact on p 23 of the Q2 report. Specifically, Scrips reported $1,133,393 in derivative liability on 12/31/13 but only $15,660 in this same liability on 6/30/14. Admittedly, to say that my understanding of derivatives is even at the fourth grade level may be a bit of a stretch, but am I wrong to conclude that eliminating over $1.1 million in derivative liability is a good thing?
Or is it your opinion that the derivative liability was merely converted to the PIPE share issuances that you and everyone under the sun here are so convinced by the facts they are being sold into the hands of innocent and unsuspecting retailers?
by the way, I do not believe the majority of the PIPE are selling
Regardless, I'm pleased to be rid of over $1.1 million in liability regardless of how it's classified. But like the rest of the core, I'm easily pleased.
Speaking of the total OS, you may disagree, but I am starting to see a trend that indicates a significant slow down to dilution. From 12/31/12 to 12/31/13, at a time where the company was in dire straits, the company's total share structure nearly doubled from 56,404,972 to 91,792,839. In the first part of the year while Scrips was still struggling and before the compounding pharmacy opportunity started to kick in, the total OS jumped to 125,610,436 on 4/8/14, about a 37% increase. Fast forward to 8/14/14 over the next 4 months with MAvP really kicking into gear, the total OS grew to 135,901,195, merely an 8% increase versus the 37% increase in the subsequent 4-month period. Moreover, based on what I can determine from what I've read so far, it appears that Bob threw the kitchen sink of non-recurring, non-cash expenses into Q2, which leads me to believe the total OS by the time the next report is published will be no higher than 5% of the most recent report. Though this last sentence is merely my opinion, the rest of this paragraph is facts.
Rather than jump to conclusions like so many here that Bob is colluding with the core
and instead of accusing the core of lacking even a fourth grade reading level
I kindly direct your attention to an except from page 11 of the report:
"Quote:
No inventory reserves have been made since all product are less than 12 months in age. The finished goods product at subcontractor is for product to be sold once we get approval from China regulators."
I don't know about you, but it appears to me based on what is available in the public space, that it is indeed the red tape in China that is holding up RapiMeds. Based on your learned posts and attention to detail, I'm certain this was a rare oversight, which I thought you'd might like to see.
While I rarely read CHP's posts
I think these investors were trying to help the company and themselves.
The .05 stock allowed them to lower their cost basis from a much higher cost/share, but at this level, they are certainly down and may not be even, never mind up, in the aggregate likeky until it gets back into the .30+++ range.
Most of us longs continue to rely on improving fundamentals
coolerheads you are assuming those who invested in company got .05 stock.
In my opnion they may have invested and convert at higher levels in which case it would not make sense for them to sell here.
Your assumption is that EVERYONE that invested got .05 shares and in my opinion you are incorrect.
Now once that paper is gone and asumming no more paper is issued would you agree that based on projections that this company will be earning money by the end of the year.
I think yoour posts are for the most part highly informative with good analysis but you are making assumptions based on all paper being .05.
Also I beleive once we get through the red tape Rapimeds will be delivered at 50% profit
regarding the June 2.7M, they've already accounted for 1.5M expenses so that would leave 1.2M profit that carries over for Q3.
Don't forget the carry over. I believe it was 2.7 mill.
July was $4.1M in Main Ave. Pharmacy. Any predictions for August?
Will we also get some PR announcing CFP?
OK, here's another one of my uninformed questions:
Why wouldn't someone with $0.05 "keep their pants on" and let the share price rise?...getting a triple or quad (hell, or more) return?
I read all the "pom-pom'ing", "pumping", "bashing", "soft bashing", repetitive, nothing new 'stuff' on this board and continue to look for the forest not the trees.
And if the explanation includes the 'same ole same ole' thanks but no thanks. Simply: Why wouldn't 'they' let 'er run? Is it just a justification for them being on the time clock? (lol)
I'm tired and bored with/of reading this crap over and over again. And I do understand that getting folks frustrated is some folks objective here but if 'they' let it run, wouldn't more folks be happy :~) rather than :~(
d
(just me not knowing WTF is the deal)